We show that without further manipulation, STOX1 overexpression by the feto-placental unit induces cardiovascular dysfunction, suggesting that this model is a handy tool for understanding the systemic endothelial dysfunction in preeclampsia and testing therapies, to improve maternal health. Here, STOX1 is linked to preeclampsia.